Scarica l'app Stockscreener
5.94
13.03%
-0.89
Dopo l'orario di chiusura:
5.37
-0.57
-9.60%
Minerva Neurosciences Inc Borsa (NERV) Ultime notizie
Minerva Neurosciences to Participate in The Citizens Life Sciences Conference - The Manila Times
Fed Meeting: Can Minerva Neurosciences Inc continue delivering strong returnsQuarterly Earnings Report & Proven Capital Preservation Tips - baoquankhu1.vn
Minerva Neurosciences (NASDAQ:NERV) Upgraded to Hold at Wall Street Zen - MarketBeat
Is Minerva Neurosciences Inc. in a consolidation phaseMarket Weekly Review & Risk Controlled Swing Alerts - mfd.ru
Minerva Neurosciences (NASDAQ:NERV) Shares Pass Above 50 Day Moving AverageHere's What Happened - MarketBeat
Weekly Earnings: Can Minerva Neurosciences Inc be recession proofTrade Risk Summary & Precise Swing Trade Entry Alerts - baoquankhu1.vn
Is Minerva Neurosciences Inc. stock showing strong momentumGold Moves & Fast Moving Trade Plans - mfd.ru
Balyasny Asset Management L.P. Acquires Significant Stake in Min - GuruFocus
Balyasny Asset Management L.P. Acquires Significant Stake in Minerva Neurosciences Inc. - GuruFocus
Minerva Neurosciences Inc expected to post a loss of 30 cents a shareEarnings Preview - TradingView
Is Minerva Neurosciences Inc. in a long term uptrendTake Profit & Safe Entry Zone Tips - mfd.ru
Aug Swings: What drives MODVs stock priceJuly 2025 Earnings & Accurate Intraday Trading Signals - baoquankhu1.vn
Balyasny discloses 4.33M-share Minerva Neurosciences (NERV) position - Stock Titan
Is Minerva Neurosciences Inc. stock attractive for growth ETFs2025 Growth vs Value & Accurate Buy Signal Notifications - mfd.ru
Minerva Neurosciences (NERV) to Release Earnings on Tuesday - MarketBeat
Minerva Neurosciences, Inc.'s (NASDAQ:NERV) market cap touched US$271m last week, benefiting both retail investors who own 55% as well as institutions - simplywall.st
Institutions profited after Minerva Neurosciences, Inc.'s (NASDAQ:NERV) market cap rose US$27m last week but individual investors profited the most - Yahoo Finance
Minerva Neurosciences, Inc (NASDAQ:NERV) Short Interest Update - MarketBeat
Will Minerva Neurosciences Inc. (4MNA) stock see valuation expansionWeekly Trend Recap & Proven Capital Preservation Tips - mfd.ru
Minerva Neurosciences Inc (NERV) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Minerva Neurosciences (NASDAQ:NERV) Stock Price Passes Above 50-Day Moving AverageWhat's Next? - MarketBeat
Minerva Neurosciences Expands Board Amid Fundraising Effort - MSN
Market Wrap: Can Minerva Neurosciences Inc continue delivering strong returnsLayoff News & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Analysts Have Conflicting Sentiments on These Healthcare Companies: Minerva Neurosciences (NERV) and Verastem (VSTM) - The Globe and Mail
Analysts Have Conflicting Sentiments on These Healthcare Companies: Minerva Neurosciences (NERV), Gossamer Bio (GOSS) and Merck & Company (MRK) - The Globe and Mail
How Minerva Neurosciences Inc. (4MNA) stock valuation compares with sectorWeekly Investment Summary & Scalable Portfolio Growth Methods - mfd.ru
Minerva Neurosciences Spotlights Roluperidone, Lays Out Confirmatory Phase 3 Timeline for Schizophrenia - MarketBeat
Minerva Outlines Confirmatory Phase 3 Plan for Roluperidone - TipRanks
Buyout Rumor: Is Minerva Neurosciences Inc subject to activist investor interest2025 Trading Recap & Real-Time Stock Entry Alerts - baoquankhu1.vn
Is Minerva Neurosciences Inc. subject to activist investor interestRate Cut & Reliable Momentum Entry Alerts - mfd.ru
Stock Analysis: Can Minerva Neurosciences Inc be recession proofJuly 2025 Setups & Momentum Based Trading Ideas - baoquankhu1.vn
Can Minerva Neurosciences Inc. stock double in the next yearJuly 2025 PreEarnings & Community Consensus Picks - mfd.ru
Minerva Neurosciences (NASDAQ:NERV) Share Price Passes Above 50-Day Moving AverageTime to Sell? - MarketBeat
Can Minerva Neurosciences Inc. stock outperform in a bear marketJuly 2025 Weekly Recap & Weekly Top Performers Watchlists - mfd.ru
Minerva Neurosciences to Host Virtual KOL Event to Discuss - GlobeNewswire
Minerva Neurosciences to Host Virtual KOL Event to Discuss Roluperidone: From Unmet Need to Reality – Potentially the First Treatment for Patients with Negative Symptoms of Schizophrenia, on February 3, 2026 - Yahoo Finance
Highs Report: Is Minerva Neurosciences Inc trading at a discountJuly 2025 Price Swings & Fast Moving Market Watchlists - baoquankhu1.vn
Minerva Neurosciences (NASDAQ:NERV) Share Price Passes Above 50 Day Moving AverageWhat's Next? - MarketBeat
Earnings Update: Can Minerva Neurosciences Inc stock double in the next yearFed Meeting & Free Long-Term Investment Growth Plans - baoquankhu1.vn
FOMO Trade: Will Minerva Neurosciences Inc benefit from seasonalityJuly 2025 Movers & Precise Entry and Exit Recommendations - baoquankhu1.vn
Downgrade Watch: Can Minerva Neurosciences Inc stock reach 100 price targetWeekly Investment Summary & Stepwise Trade Signal Guides - Bộ Nội Vụ
Gap Down: Will Minerva Neurosciences Inc 4MNA stock top growth indexes - Bộ Nội Vụ
Street Watch: Is Minerva Neurosciences Inc stock a top pick in earnings seasonVolume Spike & Real-Time Stock Movement Alerts - Bộ Nội Vụ
Wall Street Recap: Why analysts upgrade Minerva Neurosciences Inc. stock2025 Key Highlights & Verified Short-Term Trading Plans - Bộ Nội Vụ
Minerva Neurosciences (NASDAQ:NERV) Cut to Sell at Wall Street Zen - MarketBeat
What risks investors should watch in Minerva Neurosciences Inc. stockWeekly Profit Analysis & Consistent Profit Trade Alerts - Улправда
Is Minerva Neurosciences Inc. (4MNA) stock attractive for dividend growth2025 Trading Volume Trends & Long-Term Capital Growth Strategies - Улправда
Is Minerva Neurosciences Inc. stock attractive for hedge fundsJuly 2025 Technicals & Real-Time Buy Signal Notifications - Улправда
Why Minerva Neurosciences Inc. stock is in analyst buy zone2025 Analyst Calls & Long-Term Investment Growth Plans - Улправда
Is Minerva Neurosciences Inc. stock safe for conservative investorsJuly 2025 Retail & Reliable Trade Execution Plans - Улправда
Why Minerva Neurosciences Inc. stock is rated strong buyJuly 2025 Momentum & Consistent Return Investment Signals - Улправда
Will Minerva Neurosciences Inc. (4MNA) stock top growth indexes2025 Momentum Check & Reliable Momentum Entry Alerts - Улправда
3.69%
0.68%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):